Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-01

Clinical Trial Update: Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans [NA]

View source ↗

Summary

A recruiting ClinicalTrials.gov study at University Hospital Gentofte investigates pancreatic polypeptide as a modulator of amylin-induced satiety in healthy ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pancreatic polypeptide (pancreatic polypeptide)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Obesity & Overweight | NA | Status: RECRUITING